Home
NICE Guidance
Published Guidance

Beta interferon and glatiramer acetate for the treatment of multiple sclerosis

Technology appraisal guidance [TA32] Published: 23 January 2002

Guidance

This guidance has been updated and replaced by NICE technology appraisal guidance 527.